BridgeBio Pharma, Inc. (BBIO): Depreciation & Amortization
$5.43M
Year ended 2025-12-31
$5.07M
Trailing 12 months to 2026-06-30
-7.1%
3-year compound annual growth
+30.1%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.43M | -10.6% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $6.08M | -6.5% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $6.49M | -4.1% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $6.77M | +15.9% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $5.84M | +301.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $1.46M | +69.5% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $859.0K | n/a | 2022-02-25, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
Compare BBIO, TVTX, MIRM, NATR side by side · Screen every company in Pharmaceutical Preparations ↗